References
- Argentino C, Sacchetti ML, Toni D, Savoini G, D’Arcangelo E, Erminio F, Federico F, Milone FF, Gallai V, Gambi D. (1989). GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study—hemodilution + drug. Stroke, 20, 1143–1149.
- Fukano Y, Ito M. (1997). Preparation of GM1 ganglioside with sialidase-producing marine bacteria as a microbial biocatalyst. Appl Environ Microbiol, 63, 1861–1865.
- Gandini C, Kitsos M, Massolini G, de Lorenzi E, Soldi A, Caccialanza G, Kirschner G. (1990). Determination of gangliosides in parenteral dosage form by high-performance liquid chromatography. J Pharm Biomed Anal, 8, 1063–1066.
- Geisler FH, Dorsey FC, Coleman WP. (1991). Recovery of motor function after spinal-cord injury—a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med, 324, 1829–1838.
- Kanfer JN. (1969). Preparation of gangliosides. Methods Enzymol, 14, 660–664.
- Kato T, Hatanaka K. (2008). Purification of gangliosides by liquid–liquid partition chromatography. J Lipid Res, 49, 2474–2478.
- Kim UJ, Park J, Li C, Jin HJ, Valluzzi R, Kaplan DL. (2004). Structure and properties of silk hydrogels. Biomacromolecules, 5, 786–792.
- Lin JH, Liu LY, Yang MH, Lee MH. (2004). Ethyl acetate/ethyl alcohol mixtures as an alternative to Folch reagent for extracting animal lipids. J Agric Food Chem, 52, 4984–4986.
- Matsumoto A, Chen J, Collette AL, Kim UJ, Altman GH, Cebe P, Kaplan DL. (2006). Mechanisms of silk fibroin sol–gel transitions. J Phys Chem B, 110, 21630–21638.
- Peng YF, Wang XD, Wei DZ. (2007). Development of a large scale process for the conversion of polysialogangliosides to monosialotetrahexosylganglioside with a novel strain of Brevibacterium casei producing sialidase. Biotechnol Lett, 29, 885–889.
- Schneider JS, Roeltgen DP, Rothblat DS, Chapas-Crilly J, Seraydarian L, Rao J. (1995). GM1 ganglioside treatment of Parkinson’s disease: An open pilot study of safety and efficacy. Neurology, 45, 1149–1154.
- Svennerholm L, Bråne G, Karlsson I, Lekman A, Ramström I, Wikkelsö C. (2002). Alzheimer disease—effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement Geriatr Cogn Disord, 14, 128–136.
- Tatsuro Y, Haruki M, Masanobu A, Atsushi K. (1989). Preparation of monosialoganglioside. US Patent 4,868,292.
- Wang X, Kluge JA, Leisk GG, Kaplan DL. (2008). Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials, 29, 1054–1064.